Clinical Trials Directory

Trials / Sponsors / PIQUR Therapeutics AG

PIQUR Therapeutics AG

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy of Oral PQR309 in Patients With Advanced Solid Tumors
Cancer
Phase 12019-03-21
WithdrawnPQR309 in Phase 2 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma
Primary Central Nervous System Lymphoma
Phase 22017-12-01
CompletedPhase 2 Study With PQR309 in Relapsed or Refractory Lymphoma Patients
Lymphoma, Non-Hodgkin Lymphoma
Phase 22016-06-01
CompletedPQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)
Metastatic Breast Cancer
Phase 1 / Phase 22016-03-28
CompletedPQR309 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma
Primary Central Nervous System Lymphoma
Phase 22015-11-12
TerminatedStudy to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma
Glioblastoma Multiforme
Phase 22015-07-01
CompletedOpen-Label, Non Randomized Phase 2 Study With Safety Run-In
Lymphoma, Malignant
Phase 22015-05-01
CompletedA Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309
Advanced Solid Tumors
Phase 12014-01-01